Recently, Cubist Pharmaceuticals Inc. (CBST) received some encouraging news when the US Food and Drug Administration (FDA) designated its antibiotic candidate...(
read more)
On 10/24/2011 Cubist (click for archive of my blog posts re CBST) announced a buyout of Adolor(click for research page)
This deal surprised many people, but in hindsight...(
read more)
Earlier this week, Cubist Pharmaceuticals announced that they would acquire Adolor Corp for $4.25/share. The deal carried an interested provision, in which Adolor's...(
read more)